165 related articles for article (PubMed ID: 8496179)
1. 5 beta-hydroxylation by the liver. Identification of 3,5,7-trihydroxy nor-bile acids as new major biotransformation products of 3,7-dihydroxy nor-bile acids in rodents.
Schteingart CD; Hagey LR; Setchell KD; Hofmann AF
J Biol Chem; 1993 May; 268(15):11239-46. PubMed ID: 8496179
[TBL] [Abstract][Full Text] [Related]
2. Chemical synthesis and hepatic biotransformation of 3 alpha,7 alpha-dihydroxy-7 beta-methyl-24-nor-5 beta-cholan-23-oic acid, a 7-methyl derivative of norchenodeoxycholic acid: studies in the hamster.
Yoshii M; Mosbach EH; Schteingart CD; Hagey LR; Hofmann AF; Cohen BI; McSherry CK
J Lipid Res; 1991 Nov; 32(11):1729-40. PubMed ID: 1770293
[TBL] [Abstract][Full Text] [Related]
3. Bile acid N-acetylglucosaminidation. In vivo and in vitro evidence for a selective conjugation reaction of 7 beta-hydroxylated bile acids in humans.
Marschall HU; Matern H; Wietholtz H; Egestad B; Matern S; Sjövall J
J Clin Invest; 1992 Jun; 89(6):1981-7. PubMed ID: 1602004
[TBL] [Abstract][Full Text] [Related]
4. Physicochemical and biological properties of natural and synthetic C-22 and C-23 hydroxylated bile acids.
Roda A; Grigolo B; Minutello A; Pellicciari R; Natalini B
J Lipid Res; 1990 Feb; 31(2):289-98. PubMed ID: 2324648
[TBL] [Abstract][Full Text] [Related]
5. Hepatic biotransformation in rodents and physicochemical properties of 23(R)-hydroxychenodeoxycholic acid, a natural alpha-hydroxy bile acid.
Merrill JR; Schteingart CD; Hagey LR; Peng Y; Ton-Nu HT; Frick E; Jirsa M; Hofmann AF
J Lipid Res; 1996 Jan; 37(1):98-112. PubMed ID: 8820106
[TBL] [Abstract][Full Text] [Related]
6. Microbial transformation of bile acids. A unified scheme for bile acid degradation, and hydroxylation of bile acids.
Hayakawa S
Z Allg Mikrobiol; 1982; 22(5):309-26. PubMed ID: 7123999
[TBL] [Abstract][Full Text] [Related]
7. Synthesis of 24-nor-5 beta-cholan-23-oic acid derivatives: a convenient and efficient one-carbon degradation of the side chain of natural bile acids.
Schteingart CD; Hofmann AF
J Lipid Res; 1988 Oct; 29(10):1387-95. PubMed ID: 3235921
[TBL] [Abstract][Full Text] [Related]
8. 15 alpha-hydroxylation of a bile acid analogue, sodium 3 alpha,7 alpha-dihydroxy-25,26-bishomo-5 beta-cholane-26-sulfonate in the hamster.
Mikami T; Ohshima A; Mosbach EH; Cohen BI; Ayyad N; Yoshii M; Ohtani K; Kihira K; Schteingart CD; Hoshita T
J Lipid Res; 1996 Jun; 37(6):1189-97. PubMed ID: 8808753
[TBL] [Abstract][Full Text] [Related]
9. delta 22-Ursodeoxycholic acid, a unique metabolite of administered ursodeoxycholic acid in rats, indicating partial beta-oxidation as a major pathway for bile acid metabolism.
Setchell KD; Yamashita H; Rodrigues CM; O'Connell NC; Kren BT; Steer CJ
Biochemistry; 1995 Apr; 34(13):4169-78. PubMed ID: 7703228
[TBL] [Abstract][Full Text] [Related]
10. Hepatic bile acid metabolism during early development revealed from the analysis of human fetal gallbladder bile.
Setchell KD; Dumaswala R; Colombo C; Ronchi M
J Biol Chem; 1988 Nov; 263(32):16637-44. PubMed ID: 3182806
[TBL] [Abstract][Full Text] [Related]
11. Effect of side-chain shortening on the physiologic properties of bile acids: hepatic transport and effect on biliary secretion of 23-nor-ursodeoxycholate in rodents.
Yoon YB; Hagey LR; Hofmann AF; Gurantz D; Michelotti EL; Steinbach JH
Gastroenterology; 1986 Apr; 90(4):837-52. PubMed ID: 3949115
[TBL] [Abstract][Full Text] [Related]
12. Hepatocellular bile acid transport and ursodeoxycholic acid hypercholeresis.
Scharschmidt BF; Lake JR
Dig Dis Sci; 1989 Dec; 34(12 Suppl):5S-15S. PubMed ID: 2689116
[TBL] [Abstract][Full Text] [Related]
13. Metabolism of sulfonate analogs of ursodeoxycholic acid and their effects on biliary bile acid composition in hamsters.
Mikami T; Kihira K; Ikawa S; Yoshii M; Miki S; Mosbach EH; Hoshita T
J Lipid Res; 1993 Mar; 34(3):429-35. PubMed ID: 8468526
[TBL] [Abstract][Full Text] [Related]
14. Comparative studies of metabolism of simultaneously administered chenodeoxycholic acid and ursodeoxycholic acid in hamsters.
Kihira K; Yamauchi T; Kuramoto T; Une M; Yoshii M; Hoshita T
Steroids; 1994 Jul; 59(7):431-5. PubMed ID: 7974527
[TBL] [Abstract][Full Text] [Related]
15. Effect of biliary obstruction on formation and metabolism of bile acids in rat.
Danielsson H
Steroids; 1973 Oct; 22(4):567-79. PubMed ID: 4147790
[No Abstract] [Full Text] [Related]
16. Chenodeoxycholic acid synthesis in the hamster: a metabolic pathway via 3 beta, 7 alpha-dihydroxy-5-cholen-24-oic acid.
Kulkarni B; Javitt NB
Steroids; 1982 Nov; 40(5):581-9. PubMed ID: 7186687
[TBL] [Abstract][Full Text] [Related]
17. Bile acids with a cyclopropyl-containing side chain. IV. Physicochemical and biological properties of the four diastereoisomers of 3 alpha,7 beta-dihydroxy-22,23-methylene-5 beta-cholan-24-oic acid.
Roda A; Grigolo B; Aldini R; Simoni P; Pellicciari R; Natalini B; Balducci R
J Lipid Res; 1987 Dec; 28(12):1384-97. PubMed ID: 3430066
[TBL] [Abstract][Full Text] [Related]
18. Identification of a novel bile acid in swans, tree ducks, and geese: 3alpha,7alpha,15alpha-trihydroxy-5beta-cholan-24-oic acid.
Kakiyama G; Iida T; Goto T; Mano N; Goto J; Nambara T; Hagey LR; Schteingart CD; Hofmann AF
J Lipid Res; 2006 Jul; 47(7):1551-8. PubMed ID: 16648547
[TBL] [Abstract][Full Text] [Related]
19. Identification of human hepatic cytochrome p450 enzymes involved in the biotransformation of cholic and chenodeoxycholic acid.
Deo AK; Bandiera SM
Drug Metab Dispos; 2008 Oct; 36(10):1983-91. PubMed ID: 18583509
[TBL] [Abstract][Full Text] [Related]
20. Effect of side chain length on biotransformation, hepatic transport, and choleretic properties of chenodeoxycholyl homologues in the rodent: studies with dinorchenodeoxycholic acid, norchenodeoxycholic acid, and chenodeoxycholic acid.
Yeh HZ; Schteingart CD; Hagey LR; Ton-Nu HT; Bolder U; Gavrilkina MA; Steinbach JH; Hofmann AF
Hepatology; 1997 Aug; 26(2):374-85. PubMed ID: 9252148
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
